Q4 2019 Blueprint Medicines Corp Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter 2019 Blueprint Medicines Conference Call. (Operator Instructions)
And I would now like to hand the conference over to your speaker today, Kristin Hodous. Thank you, and please go ahead, ma'am.
Thank you, operator. Good morning, everyone. This is Kristin Hodous of Blueprint Medicines, and welcome to Blueprint Medicines' Fourth Quarter and Full Year 2019 Financial and Operating Results Conference Call. This morning, we issued a press release which outlines the topics that we plan to discuss today. You can access the press release as well as the slides that we'll be reviewing today by going to the Investors section of our website at www.blueprintmedicines.com.
Today on our call, Jeff Albers, our Chief Executive Officer, will discuss Blueprint Medicines' fourth quarter and full year 2019 business highlights; Dr. Andy
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |